
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 74 results:
Author Title Type [ Year
Filters: Author is Garcia Rodriguez, L. A. [Clear All Filters]
“Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study”, Lancet Diabetes Endocrinol, vol. 8, pp. 27-35, 2020.
, “Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK”, BMJ Open, vol. 9, p. e031341, 2019.
, “Prevalence of antibiotic use: a comparison across various European health care data sources”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 11-20, 2016.
, “Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding”, Thromb Haemost, vol. 110, pp. 1014-24, 2013.
, ,
,
“Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors”, Copd, vol. 6, pp. 369-79, 2009.
, “Relationship between gastroesophageal reflux disease and COPD in UK primary care”, Chest, vol. 134, pp. 1223-1230, 2008.
, “Morbidity associated with sleep disorders in primary care: a longitudinal cohort study”, Prim Care Companion J Clin Psychiatry, vol. 9, pp. 338-45, 2007.
, “Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom”, Arch Intern Med, vol. 167, pp. 935-43, 2007.
, “Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation”, Clin Cardiol, vol. 30, pp. 624-8, 2007.
, “Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity”, Int J Clin Pract, vol. 61, pp. 1663-70, 2007.
, “Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease”, Gastroenterology, vol. 130, pp. 1588-94, 2006.
, “Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications”, BMC Med, vol. 4, p. 22, 2006.
, “Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care”, Curr Med Res Opin, vol. 22, pp. 1661-8, 2006.
, “Esophageal stricture: incidence, treatment patterns, and recurrence rate”, Am J Gastroenterol, vol. 101, pp. 2685-92, 2006.
, “Hormone therapy and cerebrovascular events: a population-based nested case-control study”, Menopause, vol. 13, pp. 730-6, 2006.
, “Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population”, Heart, vol. 92, pp. 1610-5, 2006.
, “Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease”, Neurology, vol. 66, pp. 1097-9, 2006.
, “Breast cancer risk among users of antidepressant medications”, Epidemiology, vol. 16, pp. 101-5, 2005.
, “Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population”, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
, “Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK”, BMC Cardiovasc Disord, vol. 5, p. 20, 2005.
, “Prostate cancer risk among men with diabetes mellitus (Spain)”, Cancer Causes Control, vol. 16, pp. 1055-8, 2005.
, “Respiratory medications and the risk of cardiac arrhythmias”, Epidemiology, vol. 16, pp. 360-6, 2005.
, “Use of antibiotics and risk of breast cancer”, Am J Epidemiol, vol. 161, pp. 616-9, 2005.
, “Acute and clinically relevant drug-induced liver injury: a population based case-control study”, Br J Clin Pharmacol, vol. 58, pp. 71-80, 2004.
, “Breast cancer incidence and use of antihypertensive medication in women”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 581-5, 2004.
, “Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer”, Cancer Epidemiol Biomarkers Prev, vol. 13, pp. 649-53, 2004.
, “Natural history of gastro-oesophageal reflux disease diagnosed in general practice”, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
, “Risk of breast cancer among users of aspirin and other anti-inflammatory drugs”, Br J Cancer, vol. 91, pp. 525-9, 2004.
, “Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?”, Maturitas, vol. 44, pp. 133-40, 2003.
, “Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure”, Epidemiology, vol. 14, pp. 240-6, 2003.
, “Users of oral steroids are at a reduced risk of developing irritable bowel syndrome”, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
, “Respiratory medications and risk of asthma death”, Thorax, vol. 57, pp. 683-6, 2002.
, “Risk of acute liver injury in patients with diabetes”, Pharmacotherapy, vol. 22, pp. 1091-6, 2002.
, “Risk of clinical blood dyscrasia in a cohort of antibiotic users”, Pharmacotherapy, vol. 22, pp. 630-6, 2002.
, “Risk of irritable bowel syndrome among asthma patients”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 31-5, 2002.
, “Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation”, BMC Cardiovasc Disord, vol. 2, p. 5, 2002.
, “Gender and drug treatment as determinants of mortality in a cohort of heart failure patients”, Eur J Epidemiol, vol. 17, pp. 329-35, 2001.
, “Incidence of newly diagnosed heart failure in UK general practice”, Eur J Heart Fail, vol. 3, pp. 225-31, 2001.
, “Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs”, Epidemiology, vol. 12, pp. 570-6, 2001.
, “The risk of obstructive airways disease in a glaucoma population”, Pharmacoepidemiol Drug Saf, vol. 10, pp. 157-63, 2001.
, “Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations”, BMC Clin Pharmacol, vol. 1, p. 1, 2001.
, , “Are schizophrenia or antipsychotic drugs a risk factor for cataracts?”, Epidemiology, vol. 11, pp. 620-3, 2000.
, “Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome”, Scand J Gastroenterol, vol. 35, pp. 306-11, 2000.
, “Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women”, Epidemiology, vol. 11, pp. 382-7, 2000.
, “Overall mortality among patients surviving an episode of peptic ulcer bleeding”, J Epidemiol Community Health, vol. 54, pp. 130-3, 2000.
, ,